Since SORT1 is expressed in ovarian and endometrial tumors as well as in cell lines derived from these tumors, and since SORT1 binds and internalizes the TH19P01 peptide, it was next investigated whether TH1902 could be used to treat such tumors. The gene discussed is SORT1; the disease is endometrium neoplasm.